Skip to main content
Bodal Chemicals Ltd logo

Bodal Chemicals Ltd — Investor Relations & Filings

Ticker · BODALCHEM ISIN · INE338D01028 LEI · 33580055P81L7PGHUJ40 BSE.NS Manufacturing
Open in API
Filings indexed 1,550 across all filing types
Latest filing 2022-06-16 Regulatory Filings
Country IN India
Listing BSE.NS BODALCHEM

About Bodal Chemicals Ltd

https://www.bodal.com/

Bodal Chemicals Ltd is a vertically integrated manufacturer specializing in dyestuffs, dye intermediates, and basic chemicals. The product portfolio includes a wide range of reactive, acid, and direct dyes, alongside key intermediates such as H-Acid and Vinyl Sulphone. The chemical division produces sulfuric acid, chloro sulfonic acid, and liquid sulfur trioxide. By maintaining a high degree of backward integration, the company ensures cost-efficiency and consistent quality across its manufacturing chain. It serves diverse global markets, primarily catering to the textile, leather, paper, and plastic sectors. The organization focuses on large-scale production capabilities and technical expertise to provide chemical solutions for industrial applications worldwide.

Recent filings

Filing Released Lang Actions
Bodal Chemicals Limited has informed the Exchange about Unsecured creditors meeting on 21-Jul-2022
Regulatory Filings
2022-06-16 English
Bodal Chemicals Limited has informed the Exchange about Notice of NCLT Convened Meeting to be held on 21-Jul-2022
Regulatory Filings
2022-06-16 English
NCLT/ Court Convened Meeting
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice convening a meeting of equity shareholders of Bodal Chemicals Limited pursuant to an order by the National Company Law Tribunal (NCLT) for the purpose of approving a Scheme of Amalgamation. It includes meeting details, remote e-voting information, explanatory statements, annexures including the scheme, valuation report, fairness opinion, observation letters from stock exchanges, complaints report, board report, audited financials, and proxy forms. The content is focused on informing shareholders about the meeting and the proposed merger/amalgamation, with detailed supporting documents. This is not a financial report, earnings release, or management discussion, but rather a formal notice and solicitation for shareholder approval of a corporate restructuring transaction. Therefore, the document fits best under the category of Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings, especially related to mergers and schemes requiring shareholder approval.
2022-06-16 English
Bodal Chemicals Limited has informed the Exchange about Revised (In terms of new format of RPT) related party transaction for the period ended March 2022
Regulatory Filings
2022-06-06 English
Related Party Transaction
Interim / Quarterly Report Classification · 95% confidence The document is a detailed disclosure of related party transactions for the half year ended 31st March 2022, including remuneration, loans, advances, investments, and other financial dealings with key management personnel and subsidiaries. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations and provides extensive financial data for the half-year period. This type of disclosure is typically part of interim or quarterly reporting, as it covers a half-year period and contains substantive financial data and analysis. It is not merely an announcement or a certification, but a comprehensive financial disclosure for a period shorter than a full fiscal year. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H2 2022
2022-06-06 English
Transcript of Analysts/Institutional Investor Meet/Con. Call
Call Transcript Classification · 100% confidence The document is a detailed transcript of the Q4 FY22 earnings conference call of Bodal Chemicals Limited held on May 27, 2022. It includes management commentary, financial performance data for the quarter and fiscal year, segment-wise revenue breakdown, discussion of business operations, and a Q&A session with investors and analysts. The presence of a full transcript of the earnings call, including management remarks and Q&A, clearly identifies this as a Call Transcript (CT). The document is lengthy (15,000 characters) and contains substantive financial and operational discussion, not just an announcement or summary. Therefore, the appropriate classification is Call Transcript (CT).
2022-06-02 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.